A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL).
Phase of Trial: Phase IV
Latest Information Update: 24 Mar 2009
At a glance
- Drugs Atorvastatin; Pravastatin
- Indications Coronary arteriosclerosis; Hyperlipidaemia
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 18 Nov 2006 New trial record.